Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease

By Raina A.K.   Templeton D.J.   deak J.C.   Perry G.   Smith M.A.  

Redox Report, Vol. 4, Iss. 1-2, 1999-02 ,pp. : 23-27

Maney Publishing

Access to resources Recommend Favorite

Redox Active Iron at the Center of Oxidative Stress in Alzheimer Disease

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 6, 2005-09 ,pp. : 479-482

Bentham Science Publishers

Access to resources Recommend Favorite

Reactive Oxygen Species, Redox Signaling and Neuroinflammation in Alzheimer's Disease: The NF-&kgr;B Connection

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 5, 2015-03 ,pp. : 446-457

Bentham Science Publishers

Access to resources Recommend Favorite

Application of Clinical Trial Simulation to Compare Proof-of-Concept Study Designs for Drugs with a Slow Onset of Effect; An Example in Alzheimer's Disease

By Lockwood Peter   Ewy Wayne   Hermann David   Holford Nick  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2050-2059

Springer Publishing Company

Access to resources Recommend Favorite

Parkinsons Disease - Redox Mechanisms

By  

Current Medicinal Chemistry, Vol. 8, Iss. 7, 2001-06 ,pp. : 809-814

Bentham Science Publishers

Access to resources Recommend Favorite